Englander Israel A's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed May 15, 2026
- Accession no.
- 0001104659-26-062608
- Filed
- May 15, 2026, 4:24 PM ET
- Trade date
- Apr 2-7, 2026
- Filing delay
- 43 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 17 non-derivative transactions and 0 derivative transactions. Open-market purchases total $141.4K. Open-market sales total $538.1K. It was filed 43 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Englander Israel ACIK 0001017456 | 10% Owner |
| Millennium Management LLCCIK 0001273087 | 10% Owner |
| Millennium Group Management LLCCIK 0001446830 | 10% Owner |
| Ics Opportunities II LLCCIK 0001783647 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common Stock | PPurchaseAcquired | +26 | $33.47 | +$870.23 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | PPurchaseAcquired | +1,276 | $34.75 | +$44,344.06 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | PPurchaseAcquired | +701 | $35.55 | +$24,918.59 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −3,099 | $30.86 | −$95,646.92 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −1,265 | $31.75 | −$40,165.02 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −1,794 | $32.60 | −$58,491.76 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −374 | $33.35 | −$12,471.78 | 144,974 | Indirect | |
| Apr 2, 2026 | Common Stock | SSaleDisposed | −1,134 | $34.80 | −$39,463.99 | 144,974 | Indirect | |
| Apr 6, 2026 | Common Stock | PPurchaseAcquired | +1,104 | $31.02 | +$34,246.08 | 141,029 | Indirect | |
| Apr 6, 2026 | Common Stock | SSaleDisposed | −1,214 | $31.02 | −$37,661.56 | 141,029 | Indirect | |
| Apr 6, 2026 | Common Stock | SSaleDisposed | −45 | $31.96 | −$1,438.33 | 141,029 | Indirect | |
| Apr 7, 2026 | Common Stock | PPurchaseAcquired | +1,108 | $33.38 | +$36,985.04 | 133,986 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −2,115 | $28.94 | −$61,211.7 | 133,986 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −205 | $29.71 | −$6,091.49 | 133,986 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −4,423 | $31.38 | −$138,812.76 | 133,986 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −300 | $32.25 | −$9,674.01 | 133,986 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −1,108 | $33.38 | −$36,985.04 | 133,986 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.